CTNNA1 Familial Expansion Study

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 16, 2021

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Cancer Gene MutationGastric CancerBreast Cancer
Interventions
OTHER

Collection of personal and family history from CAFÉ Study participants

Personal medical and genetic history, as well as relevant information about family history, will be collected from participants in the CAFÉ Study through an online data entry system

Trial Locations (1)

19104

RECRUITING

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER